CDK4/6 inhibition in HER2-positive breast cancer. Battisti NML, Ring A. Lancet Oncol 2020 Apr 27. pii: S1470-2045(20)30164.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Battisti NML, Ring A. CDK4/6 inhibition in HER2-positive breast cancer. Lancet Oncol 2020 Apr 27. pii: S1470-2045(20)30164.
PMID: 32353343